GlassScriptPhysician profile
Suni Biju
NPI 1316462401
$2,535.54
in general payments reported to CMS, 2019-2025
10 companies · $373 in 2025
The $373 reported for 2025 was more than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $155 · 2022: $640 · 2023: $807 · 2024: $560 · 2025: $373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,740.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,740.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $681.62 | 2022-2025 | |
| Abbvie INC. | $679.17 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $459.86 | 2021-2024 | Xifaxan |
| Vifor Pharma, INC. | $124.98 | 2023 | Korsuva |
| Glaxosmithkline, LLC. | $122.91 | 2023 | Arexvy |
| Viatris Specialty LLC | $121.96 | 2025 | Yupelri |
| Takeda Pharmaceuticals U.S.A., INC. | $121.77 | 2022-2024 | Livtencity |
| Madrigal Pharmaceuticals | $113.50 | 2024 | Rezdiffra |
| Novo Nordisk INC | $94.88 | 2023 | |
| Intercept Pharmaceuticals, INC. | $14.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suni Biju listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.